Treatment of low risk gestational trophoblastic disease

Clinical Obstetrics and Gynecology

Volumn 46, Issue 3, 2003, Pages 579-592

  Carney, Michael E ^a  

^a KAPIOLANI MEDICAL CENTER FOR WOMEN AND CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; DACTINOMYCIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ALOPECIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIGESTIVE SYSTEM ULCER; DISEASE SEVERITY; DRUG MEGADOSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HYSTERECTOMY; METASTASIS POTENTIAL; NAUSEA; REMISSION; RISK ASSESSMENT; SECOND CANCER; SKIN TOXICITY; SOFT TISSUE INJURY; TOXIC HEPATITIS; TROPHOBLASTIC DISEASE; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIONIC GONADOTROPIN; DECISION TREES; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; HYSTERECTOMY; PREGNANCY; UTERINE NEOPLASMS;

EID: 0141563792     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200309000-00009     Document Type: Conference Paper

References (44)

1. Soper JT, Lewis, JL Jr, Hammond CB. Gestational trophoblastic disease. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology, 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1996;1039-65.
2. Li M, Hertz R, Spencer DB. Effects of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med. 1956;93:361.
3. Hertz R, Lewis JL, Lipsett MB. Five years experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Amer J Obstet Gynecol. 1961;82:631.
4. Ngan HY, Lopes Ad, Lauder IJ, et al. An evaluation of the prognostic factors in metastatic gestational trophoblastic disease. Int J Gynecol Cancer. 1994;4:36-42.
5. Smith DB, Holden L, Newlands ES, et al. Correlation between clinical staging (FIGO) and prognostic groups with gestational trophoblastic disease. Br J obstet Gynecol. 1993;100:157-160.
6. Soper JT, Evans AC, Conaway MR, et al. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol. 1994;84:969-973.
7. Kohom EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001; 11(1):73-77.
8. Hancock BW, Welch EM, Gillespie AM, et al. A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. Int J Gynecol Cancer. 2000; 10:318-322.
9. Suzuka K, Matsui H, Iitsuka Y, et al. Adjuvant hysterectomy in low-risk gestational trophoblastic disease. Obstet Gynecol. 2000;97:431-434.
10. Berkowitz RS, Goldstein DP. Gestational Trophoblastic Diseases. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2000; 1117-1137.
11. Hammond CB, Hertz R, Ross GT, et al. Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. Am J Obstet Gynecol. 1967;98:71-78.
12. Smith EB, Weed JC Jr, Truey L, et al. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid. Am J Obstet Gynecol. 1982; 144:88-92.
13. Lurain JR, Elfstreand EP. Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol. 1995; 172:574-579.
14. Soper JT, Clarke-Pearson DL, Berchuck A, et al. 5-day methotrexate for women with metastatic trophoblastic disease. Gynecol Oncol. 1994;54:76-79.
15. Bagshawe KD, Wilde CE. Infusion therapy for pelvic tumors. Br J Obstet Gynaecol. 1964;71:565-571.
16. Berkowitz RS, Goldstein DP, Bernstein MR. Management of nonmetastatic trophoblastic tumors. J Reprod Med. 1981;26: 219-222.
17. Bolis G, Colombo N, Epis A, et al. Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor. Tumor. 1987;73:309-313.
18. Wong LC, Choo YC, Mah K. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol. 1986; 152:59-62.
19. Mutch DG, Soper JT, Baker ME, et al. Role of comuted axial tomography of the chest in staging patients with non-metastatic gestational trophoblastic disease. Obstet Gynecol. 1986;68:348-352.
20. Bagshawe KD, Dent J, Newlands ES, et al. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumors (GTT). Br J Obstet Gynaecol. 1989;96:795-802.
21. Elit L, Covens A, Osbome R, et al. High-dose methotrexate for gestational trophoblastic disease. Gynecol Oncol. 1994;54: 282-287.
22. Garrett AP, Garner EO, Goldstein DP, et al. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. J Report Med. 2000;47:355-362.
23. Kwon JS, Elit L, Mazurka J, et al. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol. 2001;82:367-370.
24. Berkowitz RS, Goldstein DP, Bernstein MR. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors. Gynecol Oncol. 1990;36:56-59.
25. Barter JF, Soong SJ, Hatch KD, et al. Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate. Am J Obstet Gynecol. 1987; 157:1166-1168.
26. Homesley HD, Blessing JA, Rettenmaier M, et al. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol. 1988;72:413-418.
27. Hoffman MS, Fiorica JV, Gleeson NC, et al. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol. 1996;60:292-294.
28. Gleeson NC, Finan MA, Fiorica JV, et al. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid. Eur J. Gynaecol Oncol. 1993; 14:461-465.
29. Goldstein DP, Winig P, Shirley RL. Actinomycin D as initial therapy of gestational trophoblastic disease: a re-evaluation. Obstet Gynecol. 1975;45:341-345.
30. Petrilli ES, Morrow CP. Actimomycin D toxicity in the treatment of trophoblastic disease: a comparison of the five-day course to single-dose administration. Gynecol Oncol. 1980;9:18-22.
31. Twiggs CB. Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic disease: cost-effective chemotherapy. Gynecol OncoL 1983; 16:190-195.
32. Petrilli ES, Twiggs LB, Blessing JA, et al. Single-dose actinomycin D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group. Cancer. 1987; 60:2173-2176.
33. Rose PG, Piver MS. Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease. J Surg Oncol. 1989;41:148-152.
34. Sung HC, Wu PC, Ho TH. Re-evaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. Am J Obstet Gynecol. 1984; 150:69-75.
35. Wong MA, Choo YC, Ma HK. Primary oral etoposide therapy in gestational trophoblastic disease: an update. Cancer. 1986;58: 14-17
36. Matsui H, litsuka Y, Seki K, et al. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities. Gynecol Obstetln Obstet Invest. 1998;46:5-8.
37. Roberts JP, Lurain JR. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol. 1996;174:1917-1923; discussion 1923-1924.
38. McNeish IA, Strickland S, Holden L, et al. Low-risk persistent gestational tropho- blastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol. 2002;20: 1838-1844.
39. Rustin GJS, Newlands ES, Lutz JM, et al. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol. 1996;14: 2769-2773.
40. Bower M, Rustin GJS, Newlands ES, et al. Chemotherapy for gestational tropho- blastic tumours hastens menopause by 3 years. Eur J Cancer. 1998;34:1204-1207.
41. Mutch DG, Soper JT, Babcock CJ, et al. Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer. 1990;66:978-982.
42. Kohom EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001; 11:73-77.
43. Rustin GJ, Both M, Dent J, et al. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumors. Br Med J. 1984;288:103.
44. Garner EI, Lipson E, Bernstein MR, et al. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor. J Reprod Med. 2002; 47(5):380-386.